cetirizine has been researched along with Idiopathic Parkinson Disease in 1 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekimova, IV | 1 |
| Plaksina, DV | 1 |
| Pastukhov, YF | 1 |
| Lapshina, KV | 1 |
| Lazarev, VF | 1 |
| Mikhaylova, ER | 1 |
| Polonik, SG | 1 |
| Pani, B | 1 |
| Margulis, BA | 1 |
| Guzhova, IV | 1 |
| Nudler, E | 1 |
1 other study available for cetirizine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
New HSF1 inducer as a therapeutic agent in a rodent model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Cetirizine; Gene Knockdown Techniques; Heat Shock Transcription Facto | 2018 |